Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

BIOXYTRAN, INC

CIK 1445815 BIXT·Pharmaceutical Preparations · All EDGAR filings ↗

Late filing elevated Filing comparison

BIOXYTRAN, INC told the SEC it could not file its annual report on time

Does not expect a significant change in results. 1 day past the statutory due date.

The registrant is unable to file its Annual Report on Form 10-K within the prescribed time period without unreasonable effort and expense due to the limited size of its accounting staff and the timing of the completion of the audit. During the final stages of the audit, the registrant’s independent auditor proposed significant last-minute revisions to the financial statement disclosures. Given that the registrant’s financial reporting function is performed by a minimal number of personnel, the time required to incorporate these revisions, verify the underlying data, and obtain final review from the auditor exceeded the remaining time available before the original filing deadline.
Evidence
Anticipates significant change
No
Days past due date
1
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
The registrant is unable to file its Annual Report on Form 10-K within the prescribed time period without unreasonable effort and expense due to the limited size of its accounting staff and the timing of the completion of the audit. During the final stages of the audit, the registrant’s independent auditor proposed significant last-minute revisions to the financial statement disclosures. Given that the registrant’s financial reporting function is performed by a minimal number of personnel, the time required to incorporate these revisions, verify the underlying data, and obtain final review from the auditor exceeded the remaining time available before the original filing deadline.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.